Wednesday, June 10, 2026

pharma

ALK-Abelló A/S

ALK-Abelló A/S patent portfolio — 25 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Hørsholm, DK HQ
1923 Founded
EMA registrant Type
Company details
Status
Public
HQ
Hørsholm, DK
Founded
1923
Programs
0
Drugs
0
Patents
25
Intelligence · Patents

ALK-Abelló A/S patents

25 pharmaceutical patents indexed for ALK-Abelló A/S. 0 expire within 24 months.

ALK-Abelló A/S has 25 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. WO 2024200854

    ANTICORPS DE LIAISON AUX ALLERGÈNES APPROPRIÉS POUR TRAITER DES ALLERGIES AU POLLEN D'ARBRE

    Expires Wed Sep 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. EP 4302750

    ORALE DÜNNFILME ENTHALTEND ADRENALIN

    Expires Tue Jan 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. EP 4302751

    ORALE DÜNNFILME MIT GERINGER WASSERAKTIVITÄT

    Expires Tue Jan 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. CA 3259886

    DISPOSITIFS DE DÉPLACEMENT D'IGE-FCERI

    Expires Wed Dec 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. WO 2023232958

    INHIBITEURS DE LA KINASE DE BRUTON POUR LE TRAITEMENT D'UNE RÉACTION ALLERGIQUE SOUDAINE

    Expires Wed Dec 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. CA 3255134

    COMPOSITION D'ALLERGÈNE D'ARACHIDE

    Expires Wed Oct 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. WO 2019224246

    MÉTHODES FONDÉES SUR DES BIOMARQUEURS DESTINÉES AU TRAITEMENT D'UNE MALADIE ATOPIQUE PAR IMMUNOTHÉRAPIE

    Expires Wed Nov 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. HK 1249412

    PHARMACEUTICAL PRODUCT COMPRISING MITE ALLERGEN EXTRACT(S) AND A METHOD FOR THE MANUFACTURE THEREOF

    Expires Thu Oct 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. WO 2017203057

    PROTÉINES IMMUNOGÈNES ET FRAGMENTS DE CELLES-CI À PARTIR D'ACARIENS ALLERGÈNES

    Expires Wed Nov 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. WO 2017179025

    POLYPEPTIDES ÉPITOPIQUES D'ALLERGÈNES DE POLLEN D'AMBROISIE

    Expires Wed Oct 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. WO 2017004561

    ASSOCIATIONS DE PEPTIDES ET LEURS UTILISATIONS DANS LE TRAITEMENT DE L'ALLERGIE AUX GRAMINÉES

    Expires Wed Dec 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. WO 2016209959

    COMBINAISONS DE PEPTIDES ET LEUR UTILISATION DANS LE TRAITEMENT DE L'ALLERGIE AUX POLLEN DE CÈDRE

    Expires Wed Dec 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. EP 2952200

    Allergen zur vorbeugenden Behandlung von Allergien

    Expires Tue Dec 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. WO 2015131053

    POLYPEPTIDES DÉRIVÉS DE PHL P, PROCÉDÉS ET UTILISATIONS DE CES DERNIERS POUR MODULER UNE RÉPONSE IMMUNITAIRE

    Expires Wed Aug 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. CA 2933552

    ASSOCIATIONS DE PEPTIDES ET LEUR UTILISATION DANS LE TRAITEMENT DE L'ALLERGIE AUX ACARIENS

    Expires Wed Jun 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. WO 2015077442

    IMMUNOGÈNES DE POLLEN DE GRAMINÉE AINSI QUE PROCÉDÉS ET UTILISATIONS POUR LA MODULATION DE LA RÉPONSE IMMUNITAIRE

    Expires Wed May 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. CA 2931112

    IMMUNOGENES CONTRE PLUSIEURS POLLENS ET PROCEDES ET UTILISATIONS POUR MODULER LA REPONSE IMMUNITAIRE

    Expires Wed May 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. CA 2870399

    POLYPEPTIDES DE PROFILINE VEGETALE DESTINES A ETRE UTILISES DANS L'IMMUNOTHERAPIE NON SPECIFIQUE D'ALLERGIES

    Expires Wed Oct 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 2012100164

    SUPPRESSION OF A HYPERSENSITIVITY IMMUNE RESPONSE WITH UNRELATED ANTIGEN DERIVED FROM ALLERGEN SOURCE MATERIAL

    Expires Wed Apr 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 2012100163

    SUPPRESSION OF A TYPE 1 HYPERSENSITIVITY IMMUNE RESPONSE WITH AN UNRELATED ANTIGEN

    Expires Wed Apr 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. US 2012076825

    PHARMACEUTICAL PRODUCT COMPRISING MITE ALLERGEN EXTRACT(S) AND A METHOD FOR THE MANUFACTURE THEREOF

    Expires Wed Mar 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. AU 2010255748

    Stabilised composition comprising at least one adrenergic compound

    Expires Wed Dec 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. WO 2010146171

    NOUVELLE MÉTHODE D'ADMINISTRATION D'UN ALLERGÈNE DANS UNE IMMUNOTHÉRAPIE ALLERGÈNE-SPÉCIFIQUE

    Expires Wed Dec 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. CA 2739557

    PRODUIT PHARMACEUTIQUE POUR AUGMENTER LA DOSE DE VACCIN ANTI-ALLERGIQUE

    Expires Wed Apr 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. CA 2708406

    COMPOSITION DE VACCIN ANTI-ALLERGIE POUR UNE ADMINISTRATION MUCOSALE

    Expires Wed Jul 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does ALK-Abelló A/S have?

25 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do ALK-Abelló A/S patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.